Variant Alzheimer Disease With Spastic Paraparesis: Neuropathological Phenotype

Variant Alzheimer disease (varAD) is clinically characterized by the combination of presenile dementia with spastic paraparesis and is caused by certain mutations of the presenilin 1 (PS-1) gene. We now present the unusual neuropathological phenotype of varAD as seen in 5 affected members of the original Finnish family with a genomic deletion encompassing exon 9 of the PS-1 gene. Their primary and association cortices and hippocampus showed a profusion of eosinophilic, roundish structures with distinct borders termed “cotton wool” plaques (CWPs). The CWPs were immunoreactive for Aβ42/43 but weakly or not at all for Aβ40 isoforms of the amyloid β peptide (Aβ). They were devoid of a congophilic core, and fibrillar amyloid could not be identified within them by electron microscopy. Confocal microscopy showed reduced density of axons within individual CWPs and only few CWP-related PHF-tau-positive dystrophic neurites. CWPs were particularly numerous in the medial motor cortex representing the lower extremities, and degeneration of the lateral corticospinal tracts was observed at the level of the medulla oblongata and the spinal cord. In addition to the predominant CWPs, variable numbers of diffuse and cored plaques were found in the cerebral cortex. Diffuse and non-neuritic cored amyloid plaques but no CWPs occurred in the cerebellum. In conclusion, varAD in this Finnish family is distinct from classic AD because of the degeneration of lateral corticospinal tracts, predominance of CWPs devoid of fibrillar amyloid cores in the cerebral cortex, and presence of non-neuritic amyloid plaques in the cerebellum

[1]  Nick C Fox,et al.  Early onset familial Alzheimer’s disease , 2002, Neurology.

[2]  P. Schofield,et al.  Variable phenotype of Alzheimer’s disease with spastic paraparesis , 2007, Annals of neurology.

[3]  R. Terry Cell death or synaptic loss in Alzheimer disease. , 2000, Journal of neuropathology and experimental neurology.

[4]  A. Paetau,et al.  Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS‐1 mutations that lead to exceptionally high amyloid‐β concentrations , 2000, Annals of neurology.

[5]  B. Ghetti,et al.  Hereditary lateral sclerosis and Alzheimer disease associated with mutation at codon 261 of the presenilin 1 (PS1) gene , 2000, Neurobiology of Aging.

[6]  N. Foster,et al.  Early-onset familial Alzheimer's disease and spastic paraparesis associated with a novel insectional mutation of the presenilin 1 gene , 2000, Neurobiology of Aging.

[7]  P. Schofield,et al.  Variable presentation of Alzheimer's disease and/or spastic paraparesis phenotypes in pedigrees with a novel PS-1 exon 9 gene deletion or exon 9 splice acceptor mutations , 2000, Neurobiology of Aging.

[8]  S. Mead,et al.  Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. , 2000, Brain : a journal of neurology.

[9]  H. Orr,et al.  Spinocerebellar Ataxia Type 1—Modeling the Pathogenesis of a Polyglutamine Neurodegenerative Disorder in Transgenic Mice , 2000, Journal of neuropathology and experimental neurology.

[10]  J. Hardy,et al.  Variant Alzheimer’s disease with spastic paraparesis , 2000, Neurology.

[11]  R. Kraftsik,et al.  Primary motor cortex involvement in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[12]  A. Paetau,et al.  Alzheimer disease PS-1 exon 9 deletion defined , 1999, Nature Medicine.

[13]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[14]  M. Hasselmo,et al.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Storey,et al.  Early-onset Alzheimer's disease caused by a novel mutation at codon 219 of the presenilin-1 gene. , 1999, Neuroreport.

[16]  J. Holton,et al.  Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation , 1999, Acta Neuropathologica.

[17]  B. Hyman,et al.  Abeta associated neuropil changes: correlation with neuronal loss and dementia. , 1998, Journal of neuropathology and experimental neurology.

[18]  A. Hofman,et al.  Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation , 1998, Acta Neuropathologica.

[19]  B. Yankner Monster plaques: What they tell us about Alzheimer's disease , 1998, Nature Medicine.

[20]  A. Paetau,et al.  A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 , 1998, Nature Medicine.

[21]  Nick C Fox,et al.  Chromosome 14 familial Alzheimer’s disease: the clinical and neuropathological characteristics of a family with a leucine→serine (L250S) substitution at codon 250 of the presenilin 1 gene , 1998, Journal of neurology, neurosurgery, and psychiatry.

[22]  A. Ruiz-Linares,et al.  Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. , 1997, JAMA.

[23]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[24]  D. Dickson,et al.  The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.

[25]  A. Ruiz-Linares,et al.  Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation , 1997 .

[26]  T. Iwatsubo,et al.  The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Nick C Fox,et al.  Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. , 1997, Brain : a journal of neurology.

[28]  G. Schellenberg,et al.  The Clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients , 1996, Annals of neurology.

[29]  Y. Agid,et al.  A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. , 1996, Neuroreport.

[30]  D. Pollen,et al.  Familial and sporadic Alzheimer's disease , 1996, Neurology.

[31]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[32]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[33]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[34]  D. Labuda,et al.  Neutral polymorphisms in the deletion-prone regions of the dystrophin gene. , 1995, Human heredity.

[35]  Y. Agid,et al.  A large pedigree with early-onset Alzheimer's disease , 1995, Neurology.

[36]  M. Adams,et al.  The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families , 1995, Nature Genetics.

[37]  J. Hardy,et al.  Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description , 1994, Annals of neurology.

[38]  J. Haines,et al.  Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β‐amyloid precursor protein gene , 1992, Neurology.

[39]  J. Hardy,et al.  Pathological changes in the brain of a patient with familial Alzheimer's disease having a missense mutation at codon 717 in the amyloid precursor protein gene , 1992, Neuroscience Letters.

[40]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.

[41]  J. Ulrich,et al.  Alzheimer's Disease: A Description of the Structural Lesions , 1991, Brain pathology.

[42]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[43]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[44]  G. Plant,et al.  Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. , 1990, Brain : a journal of neurology.

[45]  G. Glenner,et al.  Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease , 1988, Journal of neurochemistry.

[46]  C. Worster-Drought,et al.  A FORM OF FAMILIAL PRESENILE DEMENTIA WITH SPASTIC PARALYSIS , 1944 .

[47]  C. Worster-Drought,et al.  A FORM OF FAMILIAL PRESENILE DEMENTIA WITH SPASTIC PARALYSISINCLUDING THE PATHOLOGICAL EXAMINATION OF A CASE , 1940 .